University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? : A protocol for the MEL-SELF randomised controlled trial

Simple item page
dc.contributor.authorAckermann, Deonna M.
dc.contributor.authorSmit, Amelia K.
dc.contributor.authorJanda, Monika
dc.contributor.authorvan Kemenade, Cathelijne H.
dc.contributor.authorDieng, Mbathio
dc.contributor.authorMorton, Rachael L.
dc.contributor.authorTurner, Robin M.
dc.contributor.authorCust, Anne E.
dc.contributor.authorIrwig, Les
dc.contributor.authorHersch, Jolyn K.
dc.contributor.authorGuitera, Pascale
dc.contributor.authorSoyer, H. Peter
dc.contributor.authorMar, Victoria
dc.contributor.authorSaw, Robyn P.M.
dc.contributor.authorLow, Donald
dc.contributor.authorLow, Cynthia
dc.contributor.authorDrabarek, Dorothy
dc.contributor.authorEspinoza, David
dc.contributor.authorEmery, Jon
dc.contributor.authorMurchie, Peter
dc.contributor.authorThompson, John F.
dc.contributor.authorScolyer, Richard A.
dc.contributor.authorAzzi, Anthony
dc.contributor.authorLilleyman, Alister
dc.contributor.authorBell, Katy J.L.
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.date.accessioned2021-05-26T08:54:01Z
dc.date.available2021-05-26T08:54:01Z
dc.date.issued2021-05-04
dc.descriptionThis research project is funded by a National Health and Medical Research Council (NHMRC) Project grant (#1163054). The funder had no role in the design of the study and will have no role in the collection, analysis, and interpretation of the data; the writing of the report; or the decision to submit the report for publication. Funding Information: AEC is funded by a Career Development Fellowship from the National Health and Medical Research Council (NHMRC; 1147843). JFT is a recipient of an NHMRC Program Grant (1093017). RPMS is supported by Melanoma Institute Australia. RAS is supported by a NHMRC Program Grant and Practitioner Fellowship. For RAS, support from the from colleagues at Melanoma Institute Australia, Royal Prince Alfred Hospital and NSW Health Pathology is also gratefully acknowledged. RLM is supported with an NHMRC Investigator grant (1194703) and a University of Sydney Robinson Fellowship. HPS holds an NHMRC MRFF Next Generation Clinical Researchers Program Practitioner Fellowship (APP1137127). JH is supported by an NHMRC Early Career Fellowship (1112509). KB is supported by an NHMRC Investigator Grant (1174523) and a University of Sydney Research Accelerator (SOAR) Prize.en
dc.description.statusPeer revieweden
dc.format.extent18
dc.format.extent2298873
dc.identifier193911993
dc.identifier814be9a5-5f64-47ee-9995-23dcc39b07cf
dc.identifier85105502711
dc.identifier33947444
dc.identifier000656359100003
dc.identifier.citationAckermann, D M, Smit, A K, Janda, M, van Kemenade, C H, Dieng, M, Morton, R L, Turner, R M, Cust, A E, Irwig, L, Hersch, J K, Guitera, P, Soyer, H P, Mar, V, Saw, R P M, Low, D, Low, C, Drabarek, D, Espinoza, D, Emery, J, Murchie, P, Thompson, J F, Scolyer, R A, Azzi, A, Lilleyman, A & Bell, K J L 2021, 'Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial', Trials, vol. 22, no. 1, 324. https://doi.org/10.1186/s13063-021-05231-7en
dc.identifier.doi10.1186/s13063-021-05231-7
dc.identifier.iss1en
dc.identifier.issn1745-6215
dc.identifier.otherORCID: /0000-0001-9968-5991/work/95223184
dc.identifier.urihttps://hdl.handle.net/2164/16541
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85105502711&partnerID=8YFLogxKen
dc.identifier.vol22en
dc.language.isoeng
dc.relation.ispartofTrialsen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectCancer surveillanceen
dc.subjectEarly detection of canceren
dc.subjectHealth services researchen
dc.subjectMelanomaen
dc.subjectRandomised controlled trialen
dc.subjectSelf-examinationen
dc.subjectTeledermoscopyen
dc.subjectTelehealthen
dc.subjectR Medicineen
dc.subjectMedicine (miscellaneous)en
dc.subjectPharmacology (medical)en
dc.subjectOtheren
dc.subject1147843en
dc.subject1163054en
dc.subject1093017en
dc.subject1194703en
dc.subjectAPP1137127en
dc.subject1174523en
dc.subjectSupplementary Informationen
dc.subject.lccRen
dc.titleCan patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? : A protocol for the MEL-SELF randomised controlled trialen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Ackermann_etal_can_patient_led_surveillance_VOR.pdf
Size:
2.19 MB
Format:
Adobe Portable Document Format
Download

Collections

All research